APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 20 filers reported holding APTEVO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | -77.8% | 6 | 0.0% | 0.00% | – |
Q2 2023 | $9 | -25.0% | 6 | 0.0% | 0.00% | – |
Q1 2023 | $12 | -53.8% | 6 | -45.5% | 0.00% | – |
Q4 2022 | $26 | -99.6% | 11 | -99.4% | 0.00% | – |
Q3 2022 | $6,000 | – | 1,954 | +32466.7% | 0.00% | – |
Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 6 | -79.3% | 0.00% | – |
Q3 2021 | $0 | – | 29 | +222.2% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 9 | -99.5% | 0.00% | – |
Q1 2021 | $56,000 | -70.7% | 1,846 | -64.5% | 0.00% | – |
Q4 2020 | $191,000 | – | 5,205 | +74257.1% | 0.00% | – |
Q3 2020 | $0 | – | 7 | -70.8% | 0.00% | – |
Q2 2020 | $0 | – | 24 | +242.9% | 0.00% | – |
Q1 2020 | $0 | – | 7 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |